MASI
MASIMO CORP
Key Financials
Gross Profit
$945.2M
↓ 5.9%
Net Income
$-151500000
↑ 50.3%
Revenue
$1.5B
↓ 27.1%
Operating Income
$310.0M
↑ 216.2%
EPS (Diluted)
$-2.80
↑ 51.0%
Shareholders' Equity
$721.2M
↓ 31.4%
Total Assets
$1.7B
↓ 35.3%
Total Liabilities
$977.7M
↓ 37.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFM14A | 4/1/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| PREM14A | 3/18/2026 | View on SEC |
| 4 | 3/16/2026 | View on SEC |
| 4 | 3/16/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MASI |
| Company Name | MASIMO CORP |
| CIK | 937556 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0103 |
| State of Incorporation | DE |
| Phone | 949-297-7000 |